Replies to post #55528 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

True, but only if one does not trust the source, accuracy or that the outcome is representative. All the data and outcomes reported so far align almost perfectly with the outcomes of the xenograft Nude Mice studies. The only variance is that p21 and tumor arrest have come at slightly lower doses than the nude mouse outcomes predicted.

But, the market seems to be in a Missouri (show me) state of mind where nothing will be believed until it comes from a report filed with the FDA, which is that thing I referred to Saturday as "reverse exceptionalism." Huge price moves north on the most meager of evidence for all biopharmas except CTIX.

One patient showing 'signs' of tumor regression reported informally during an investors' conference isn't exactly substantial or convincing evidence, esp without any details whatsoever.